S. J. Goldie

2.8k total citations
25 papers, 2.1k citations indexed

About

S. J. Goldie is a scholar working on Epidemiology, Surgery and Oncology. According to data from OpenAlex, S. J. Goldie has authored 25 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 7 papers in Surgery and 6 papers in Oncology. Recurrent topics in S. J. Goldie's work include Cervical Cancer and HPV Research (11 papers), Global Cancer Incidence and Screening (6 papers) and Genital Health and Disease (5 papers). S. J. Goldie is often cited by papers focused on Cervical Cancer and HPV Research (11 papers), Global Cancer Incidence and Screening (6 papers) and Genital Health and Disease (5 papers). S. J. Goldie collaborates with scholars based in United States, Canada and France. S. J. Goldie's co-authors include Jane J. Kim, Eduardo L. Franco, F. Xavier Bosch, Milton C. Weinstein, Daniel Grima, Thomas C. Wright, Michele Kohli, Karen M. Kuntz, David N. Fisman and Adolf W. Karchmer and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Clinical Infectious Diseases and American Journal of Epidemiology.

In The Last Decade

S. J. Goldie

24 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. J. Goldie United States 16 1.5k 703 445 258 239 25 2.1k
Ralph P. Insinga United States 32 2.4k 1.6× 1.1k 1.5× 698 1.6× 239 0.9× 78 0.3× 50 3.3k
Anne F. Rositch United States 28 1.7k 1.2× 598 0.9× 1.0k 2.3× 205 0.8× 174 0.7× 112 2.8k
Mulindi Mwanahamuntu Zambia 22 1.2k 0.8× 363 0.5× 746 1.7× 135 0.5× 236 1.0× 63 1.7k
Carla J. Chibwesha United States 20 953 0.6× 224 0.3× 492 1.1× 136 0.5× 344 1.4× 70 1.5k
Iacopo Baussano France 26 2.0k 1.3× 728 1.0× 480 1.1× 308 1.2× 720 3.0× 81 2.7k
Chad J. Achenbach United States 28 707 0.5× 355 0.5× 617 1.4× 87 0.3× 964 4.0× 124 2.5k
Markowitz Le United States 4 1.8k 1.2× 562 0.8× 197 0.4× 624 2.4× 197 0.8× 6 2.2k
Christina Dorell United States 20 2.1k 1.4× 652 0.9× 424 1.0× 1.3k 5.1× 304 1.3× 23 2.9k
Victor Mudenda Zambia 21 913 0.6× 362 0.5× 355 0.8× 43 0.2× 691 2.9× 53 1.7k
Cynthia Firnhaber South Africa 22 1.0k 0.7× 438 0.6× 368 0.8× 29 0.1× 475 2.0× 81 1.5k

Countries citing papers authored by S. J. Goldie

Since Specialization
Citations

This map shows the geographic impact of S. J. Goldie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. J. Goldie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. J. Goldie more than expected).

Fields of papers citing papers by S. J. Goldie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. J. Goldie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. J. Goldie. The network helps show where S. J. Goldie may publish in the future.

Co-authorship network of co-authors of S. J. Goldie

This figure shows the co-authorship network connecting the top 25 collaborators of S. J. Goldie. A scholar is included among the top collaborators of S. J. Goldie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. J. Goldie. S. J. Goldie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carvalho, Natalie, et al.. (2015). Maternal mortality reported trends in Afghanistan: Too good to be true? Analysis paper.. 1 indexed citations
2.
Goldie, S. J., et al.. (2013). A footballer's finger injury. BMJ. 347(aug15 1). f5069–f5069. 1 indexed citations
3.
Goldie, S. J. & Norman Daniels. (2011). Model-Based Analyses to Compare Health and Economic Outcomes of Cancer Control: Inclusion of Disparities. JNCI Journal of the National Cancer Institute. 103(18). 1373–1386. 16 indexed citations
4.
Kim, Jane J. & S. J. Goldie. (2009). Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States. BMJ. 339(oct08 2). b3884–b3884. 173 indexed citations
5.
Díaz, Mireia, G. Albero, Sílvia de Sanjosé, et al.. (2008). Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India. British Journal of Cancer. 99(2). 230–238. 103 indexed citations
6.
Goldhaber‐Fiebert, Jeremy D., et al.. (2008). Cost-Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16,18 Vaccination. JNCI Journal of the National Cancer Institute. 100(5). 308–320. 161 indexed citations
7.
Saslow, Debbie, Philip E. Castle, J. Thomas Cox, et al.. (2007). American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors. CA A Cancer Journal for Clinicians. 57(1). 7–28. 373 indexed citations
8.
Kim, Jinju, Karen M. Kuntz, Salaheddin M. Mahmud, et al.. (2007). Multiparameter Calibration of a Natural History Model of Cervical Cancer. American Journal of Epidemiology. 166(2). 137–150. 126 indexed citations
9.
Goldie, S. J., et al.. (2007). The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting. British Journal of Cancer. 97(9). 1322–1328. 126 indexed citations
10.
Franco, Eduardo L., et al.. (2007). THE AUTHORS REPLY. American Journal of Epidemiology. 166(8). 983–984. 2 indexed citations
11.
Sax, Paul E., Rafiqul Islam, Rochelle P. Walensky, et al.. (2005). Should Resistance Testing Be Performed for Treatment-Naive HIV-Infected Patients? A Cost-Effectiveness Analysis. Clinical Infectious Diseases. 41(9). 1316–1323. 138 indexed citations
12.
Kim, Jinju, GM Leung, Pauline Woo, & S. J. Goldie. (2004). Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong. Journal of Public Health. 26(2). 130–137. 27 indexed citations
13.
Goldie, S. J., Michele Kohli, Daniel Grima, et al.. (2004). Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine. JNCI Journal of the National Cancer Institute. 96(8). 604–615. 410 indexed citations
14.
Goldie, S. J., et al.. (2004). HPV Communication: Review of Existing Research and Recommendations for Patient Education. CA A Cancer Journal for Clinicians. 54(5). 248–259. 115 indexed citations
15.
Goldie, S. J.. (2003). Chapter 15: Public Health Policy and Cost-Effectiveness Analysis. JNCI Monographs. 2003(31). 102–110. 34 indexed citations
16.
Yazdanpanah, Yazdan, S. J. Goldie, A. David Paltiel, et al.. (2003). Prevention of Human Immunodeficiency Virus–Related Opportunistic Infections in France: A Cost‐Effectiveness Analysis. Clinical Infectious Diseases. 36(1). 86–96. 22 indexed citations
17.
Goldie, S. J., et al.. (2002). Assessing the Sensitivity of Decision-Analytic Results to Unobserved Markers of Risk: Defining the Effects of Heterogeneity Bias. Medical Decision Making. 22(3). 218–227. 34 indexed citations
18.
Fisman, David N., Donald T. Reilly, Adolf W. Karchmer, & S. J. Goldie. (2001). Clinical Effectiveness and Cost-Effectiveness of 2 Management Strategies for Infected Total Hip Arthroplasty in the Elderly. Clinical Infectious Diseases. 32(3). 419–430. 137 indexed citations
19.
Paltiel, A. David, S. J. Goldie, Elena Losina, et al.. (2001). Preevaluation of Clinical Trial Data: The Case of Preemptive Cytomegalovirus Therapy in Patients with Human Immunodeficiency Virus. Clinical Infectious Diseases. 32(5). 783–793. 25 indexed citations
20.
Angoff, Nancy R. & S. J. Goldie. (1998). Teaching care of terminally ill patients: a primary care perspective.. PubMed. 62(3). 139–42. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ralph P. Insinga Breakdown of academic impact, for papers by Anne F. Rositch Breakdown of academic impact, for papers by Mulindi Mwanahamuntu Breakdown of academic impact, for papers by Carla J. Chibwesha Breakdown of academic impact, for papers by Iacopo Baussano Breakdown of academic impact, for papers by Chad J. Achenbach Breakdown of academic impact, for papers by Markowitz Le Breakdown of academic impact, for papers by Christina Dorell Breakdown of academic impact, for papers by Victor Mudenda Breakdown of academic impact, for papers by Cynthia Firnhaber
Rankless by CCL
2026